New Platform for Next Generation Immunotherapy with Anish Suri Cue Biopharma TRANSCRIPT
Download PDFDec 5, 2019
Anish Suri, President and Chief Scientific Officer, Cue Biopharma discusses their proprietary Immuno-STAT(tm) platform. Cue Biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. ...
Dec 5, 2019
Anish Suri, President and Chief Scientific Officer, Cue Biopharma discusses their proprietary Immuno-STAT(tm) platform. Cue Biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. ...
Targets of Opportunity for Medicinal Cannabis Research with Dr. Igor Grant CMCR UCSD TRANSCRIPT
Download PDFNov 19, 2019
Dr. Igor Grant, Director, Center for Medicinal Cannabis Research at the University of California San Diego talks about the need for basic science studies on new indications and promises of cannabinoids, potential medical effects of both THC and CBD, the uptick in funding for clinical studies, relative safety of cannabis...
Nov 19, 2019
Dr. Igor Grant, Director, Center for Medicinal Cannabis Research at the University of California San Diego talks about the need for basic science studies on new indications and promises of cannabinoids, potential medical effects of both THC and CBD, the uptick in funding for clinical studies, relative safety of cannabis...
Developments in Prostate Cancer Treatment with Dr. Mark Scholz Medical Oncologist TRANSCRIPT
Download PDFNov 12, 2019
Dr. Mark Scholz, author and medical oncologist specializes in prostate cancer and he is determined to change the way the most common cancer in men is being diagnosed and treated. Currently, prostate cancer is the only cancer treatment managed by a surgeon and not an oncologist, reflecting the days when the only answer...